Table 3.
Summary of adverse events and adherence across studies.
| Study | Adverse events | Adherence | |||
|
|
Safety management | Number of adverse events | Adherence management | Dropout rate, n (%) | Reasons for dropout |
| Alves da Cruz et al, 2020 [18] |
|
|
NRa | 0 | NR |
| Jaarsma et al, 2020 [20] |
|
|
|
71 (23%) |
|
| Klompstra et al, 2013 [21] |
|
|
|
0 | NR |
| Klompstra et al, 2014 [22] |
|
|
|
1 (3%) |
|
| Ruivo et al, 2017 [19] |
|
|
|
1 (6.3%) |
|
aNR: not reported.